Polyphenols and cancer: the science behind eating the rainbow
One of the most persistent pieces of nutritional advice is to “eat the rainbow” — to consume vegetables and fruits across different colours. The reasoning is usually vague: “they have different nutrients” or “it’s good for you.” But when it comes to cancer prevention and survival, there’s a specific reason this advice has traction in the evidence literature.
That reason is polyphenols — a vast family of plant compounds with measurable anti-inflammatory and antioxidant properties. The emerging evidence, whilst still preliminary in some areas, is promising enough that polyphenol intake has become a focus of cancer prevention research.
What polyphenols are, and why they matter
Polyphenols are plant-derived compounds characterised by multiple phenol rings in their chemical structure. Thousands of different polyphenols exist. They’re responsible for much of the colour in plant foods — the deep purple of blueberries, the red of pomegranates, the green of tea. Plants produce them partly as defences against oxidative stress from sunlight, partly as antimicrobial compounds.
When you consume polyphenols, your gut microbiome metabolises many of them, producing smaller bioactive compounds that enter the bloodstream. Others are absorbed directly. The result is that polyphenol-rich diets increase circulating levels of numerous bioactive metabolites — some of which have been shown in mechanistic studies to inhibit cancer cell proliferation, reduce inflammation, and support anti-tumour immune responses.
The major classes include flavonoids (found in berries, tea, and dark chocolate — including quercetin, catechins, and anthocyanins), phenolic acids (found in whole grains, legumes, and coffee), and tannins (found in tea, coffee, and red wine). What they share is bioactivity: they interact with cells, modulate inflammatory pathways, and influence gene expression in ways that are relevant to cancer biology.
What the research shows: polyphenols and cancer risk
The observational evidence linking polyphenol-rich dietary patterns to lower cancer incidence is substantial across multiple large prospective cohort studies.
A 2022 systematic review and meta-analysis published in Molecules, synthesising data from 21 prospective cohort studies, found that the highest category of polyphenol intake was associated with approximately a 10–15% reduction in overall cancer incidence compared to the lowest category. The association was strongest for colorectal cancer (approximately 20% risk reduction) and breast cancer (approximately 12% risk reduction).
Data from the EPIC cohort — one of the largest prospective nutritional studies in Europe, following over 500,000 adults — found that people in the highest quartile of polyphenol intake had a hazard ratio of approximately 0.82 for colorectal cancer compared to the lowest quartile: roughly an 18% lower risk. This held after adjustment for a wide range of potential confounders including smoking, physical activity, and BMI.
These are prospective cohort studies, not RCTs, so causality cannot be definitively established. But the consistency across cancer types and populations, combined with robust biological mechanisms, makes a purely confounded explanation unlikely.
Polyphenols and epigenetic age: the DIRECT PLUS trial
More recently, interest has focused on whether polyphenols influence epigenetic age — the rate at which DNA methylation patterns shift with time, which is associated with cancer risk and discussed in Post 8 of this series.
The DIRECT PLUS randomised controlled trial, published in BMC Medicine in 2023, tested a green-Mediterranean diet — a standard Mediterranean diet with particular emphasis on green vegetables, legumes, nuts, and polyphenol-rich foods, and reduced red and processed meat — in 256 participants over 18 months. The researchers measured epigenetic age using the Levine clock, a validated DNA methylation-based measure of biological ageing.
People assigned to the green-Mediterranean diet showed a reduction in epigenetic age of approximately 8.9 months compared to controls — a finding that persisted after adjustment for weight loss, suggesting the polyphenol content specifically (rather than caloric restriction alone) was driving the effect. This is the clearest RCT evidence yet that polyphenol-rich dietary patterns have measurable effects on biological ageing processes linked to cancer risk.
What this means in practice
The polyphenol content of foods varies widely, even within food categories. Processing, storage, and cooking all affect polyphenol concentrations. The most reliably high-polyphenol foods are berries (blueberries, blackberries, raspberries, strawberries), dark leafy greens, colourful vegetables including artichokes and broccoli, whole grains, legumes, nuts and seeds, green and black tea, coffee, and dark chocolate at 70% cocoa or higher.
A typical Mediterranean dietary pattern provides 500–1,500 mg of polyphenols per day. A typical Western diet provides roughly 200–400 mg — approximately a third of the amount associated with reduced cancer incidence in epidemiological studies. The practical gap is significant, but it’s not difficult to close: the “eat the rainbow” principle translates directly into higher polyphenol intake when applied consistently.
In practical terms: aim for multiple servings of vegetables across different colours each day, include a small handful of nuts and seeds regularly, choose whole grains over refined grains, and favour green or black tea alongside coffee as your main drinks. The variety matters as much as the volume — different polyphenol classes interact with different biological pathways, so a diverse plant intake is more protective than a high intake of a single food.
What the evidence does not yet show
There are no completed large RCTs testing whether increasing polyphenol intake reduces cancer incidence or improves survival in cancer patients. The epidemiological evidence is robust, but observational studies cannot fully exclude confounding — people who eat polyphenol-rich diets may differ in many other ways from those who don’t.
Isolated polyphenol supplements are a growing market, but the evidence does not support them as equivalents to whole-food intake. A 2022 systematic review found that polyphenol supplement trials showed substantially weaker evidence of benefit than cohort studies of dietary polyphenol intake, suggesting the whole-food context — the fibre, additional micronutrients, and microbiome interactions — matters significantly.
There is also no established threshold for how much polyphenol intake is needed for meaningful cancer risk reduction. The epidemiological studies show a dose–response relationship, but the precise amount for optimal cancer protection remains uncertain.
The bottom line
Polyphenols are one piece of a broader cancer-preventive dietary pattern. The evidence supporting “eat the rainbow” is not tradition or sentiment — it’s epidemiology showing that people who consume diverse, polyphenol-rich plant foods have lower cancer incidence and, in at least one well-designed RCT, slower biological ageing. The DIRECT PLUS trial’s finding that a green-Mediterranean diet attenuated epigenetic age by nearly nine months is a meaningful data point, even if it is preliminary.
Polyphenols work best as whole foods, not supplements, and they’re most protective when combined with the foundational lifestyle factors covered throughout this series: metabolic health, consistent movement, adequate sleep, and stress management. The practical approach is straightforward — expand the variety and volume of colourful plant foods on your plate, and maintain that variety over time. Not as a rigid rule, but as a principle: the more diverse and colourful your diet, the more support you’re giving your body’s anti-cancer defences.
Scientific references
- Zamora-Ros R, Cayssials V, Jenab M, et al. Dietary intake of total polyphenol and polyphenol classes and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. European Journal of Epidemiology. 2018;33(11):1063–1075. PMID: 29761424. DOI: 10.1007/s10654-018-0408-6
- Yaskolka Meir A, Katz A, Tuohy K, et al. Green-Mediterranean diet and epigenetic age: results from the DIRECT PLUS randomised controlled trial. BMC Medicine. 2023;21(1):99. DOI: 10.1186/s12916-023-03067-3
- Dryer-Beers ER, Griffin J, Matthews PM, Frost GS. Higher dietary polyphenol intake is associated with lower blood inflammatory markers. Journal of Nutrition. 2024;154(8):2470–2480. PMID: 38740187. DOI: 10.1016/j.tjnut.2024.05.005
- Farvid MS, Barnett JB, Spence ND. Fruit and vegetable consumption and incident breast cancer: a systematic review and meta-analysis of prospective studies. British Journal of Cancer. 2021;125(2):284–298. PMID: 33828249. DOI: 10.1038/s41416-021-01373-2
- Mazzocchi A, Leone L, Agostoni C, Pali-Schöll I. The secrets of the Mediterranean diet. Does [only] olive oil matter? Nutrients. 2019;11(12):2941. PMID: 31817038. DOI: 10.3390/nu11122941
This article is written for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, prevent, or cure any medical condition, including cancer. If you have a cancer diagnosis or are undergoing treatment, please discuss any lifestyle or dietary changes with your oncologist or medical team before making them. The studies cited reflect current research at the time of writing; the field is evolving rapidly and findings may be updated or superseded. Chloe Archard is a nutritional health coach, not a medical doctor.
